title: Infection control practices in patients with hematological malignancies and multidrug-resistant organisms: special considerations and challenges.
abstract: Infectious complications contribute greatly to morbidity and mortality in patients with hematological malignancies. As these patients undergo prolonged chemotherapy and are in frequent contact with health care settings, they are at high risk for nosocomial and health care-associated infections. This long-term relationship with the hospital setting represents a major opportunity for infection prevention. In this review, we describe several infection control strategies that are currently used to reduce the transmission of hospital-acquired infections in patients with hematological malignancies, particularly infections with multidrug-resistant organisms.
authors.affiliation: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
authors.forename: Ella J
authors.initials: EJ
authors.lastname: Ariza-Heredia
authors.affiliation: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address: rfchemaly@mdanderson.org.
authors.forename: Roy F
authors.initials: RF
authors.lastname: Chemaly
mesh_terms: D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D019337:Hematologic Neoplasms / Q000150:complications*; D006801:Humans; D017053:Infection Control / Q000379:methods; D007239:Infections / Q000188:drug therapy* / Q000209:etiology*
keywords: Health-care associated infections; Hematological malignancies; Infection control; Multidrug-resistant organisms; prevention